What to watch with CYP1A2 and Darmgesundheit?

The combination of CYP1A2 and gut health is not directly supported by the provided context. CYP1A2 is primarily known for its role in caffeine metabolism and some drug metabolism. While there is emerging research on its involvement in metabolizing dietary compounds that may affect the gut barrier, the evidence is weak and mostly mechanistic. The context repeatedly states that commercial DNA and microbiome tests lack clinical validation and are often marketing-driven. No robust evidence links CYP1A2 genotyping to actionable gut health advice. Therefore, be cautious: such tests may overstate their relevance. For genuine digestive issues, consult a healthcare professional rather than relying on direct-to-consumer genetic tests. Evidence grade: unclear/marketing.